Notably, DNMT1 and UHRF1, a E3 ligase that mediates DNA targeting of DNMT1, are widely overexpressed in cancer53, including AMLs54, suggesting that aberrant expression of DNMT1 may also generate CpG hyper-methylation in cancer cells, as shown in model systems55. The gene discussed is DNMT1; the disease is cancer.